ReviewCurrent hematologic malignancy reports2020

Mechanisms of Cardiovascular Toxicity of BCR-ABL1 Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia.

Dakota Gustafson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.